96
WHO RECOMMENDED TESTS FOR TB -DR. PRAPULLA CHANDRA

WHO recommended tests of tuberculosis

Embed Size (px)

Citation preview

Page 1: WHO recommended tests of tuberculosis

WHO RECOMMENDED TESTS FOR TB

-DR. PRAPULLA CHANDRA

Page 2: WHO recommended tests of tuberculosis

INTRODUCTION• Tuberculosis (TB) remains one of the world’s deadliest communicable

diseases. • In 2013, an estimated 9 million people developed TB and 1.5 million

died from the disease.• Of the estimated 9 million people, india accounts for 24% 0f the

cases.

Page 3: WHO recommended tests of tuberculosis

• In 2013, about 64% of the estimated 9 million people who developed TB were notified as newly diagnosed cases. That is, the remaining 3 million cases were either not diagnosed, or diagnosed but not reported to national TB programmes (NTPs).

• Early diagnosis of TB and initiating optimal treatment would not only enable cure of an individual patient but also will curb the transmission of infection and disease to others in the community.

Page 4: WHO recommended tests of tuberculosis

TESTS ENDORSED BY WHO

• MICROSCOPY -light and LED microscopy -same day diagnosisCULTURE BASED TESTS -commercial liquid culture systems and rapid speciation -non commercial culture and DST (MODS, NRA, CRI)MOLECULAR TESTS -line probe assays -Xpert MTB/RIF

Page 5: WHO recommended tests of tuberculosis

WHO RECOMMENDATIONS ON NEW TECHNOLOGIES 2006-2010

Year Policy Recommended

2007 Commercial Liquid Cultures (Automated and Manual) and DSTRapid Speciation –using immuno-chromatographic assays

2008 Line Probe Assays (LPA)

2009 LED based FM and Dual Mode Systems including low load settingsNon-Commercial Methods for Culture & DST (MODS, CRI, NRA etc)

2010 Automated Cartridge Based Nucleic acid technologies – Xpert

Page 6: WHO recommended tests of tuberculosis
Page 7: WHO recommended tests of tuberculosis

DIRECT METHODS• Direct microscopy ( ZN, KINYOUN, FLUOROCHROME)• Culture ( traditional, rapid methods)• Detection of DNA/RNA of mycobacterial origin (PCR, LCR, LAMP, NAA, FAST PLAQUE)

Page 8: WHO recommended tests of tuberculosis

DIRECT MICROSCOPIC EXAMINATION• Hallmark of staining is Ziehl-neelsen staining slides• Easiest & quickest diagnostic test• Limited sensitivity (46-78%) but specificity is almost 100%• Centrifugation & fluorochrome staining (auramine O) with UV

microscopy markedly increase the sensitivity & a large no. of slides can be examined in a much shorter time.

Page 9: WHO recommended tests of tuberculosis

CONCENTRATION METHODS FOR SMEARS• Autoclaving• 1% sodium hypochlorite• Sputum treated with 2-4% NAOH• Urine, c.s.f, pleural fluids centrifused and deposit

Page 10: WHO recommended tests of tuberculosis

Decontamination

• Eliminate normal flora from the non-sterile samples (micobacteria is acid and alkaline resistant)• Homogenization to release the bacteria from the sample and allow access to the nutrient present in the media

N-acetyl-cysteine: homogenizationNaOH: decontaminantNeutralization by phosphate bufferTransportation: 1% cetyl pyridium chloride

Homogenization

Sample mixing

Phosphate buffer

Centrifugation

Pellet

Page 11: WHO recommended tests of tuberculosis

• Sputum Concentration and decontamination methods are not recommended by WHO as there is no sufficient evidence.

Page 12: WHO recommended tests of tuberculosis

Z-N staining method

Primary stain: Carbol-fuschin solution 0.3%• Decolourising agent: 3% alcohol, or 20% Sulphuric acid• Counterstain: Methylene blue 0.3%• Observe under microscope

Page 13: WHO recommended tests of tuberculosis
Page 14: WHO recommended tests of tuberculosis

Microscopy- precautions

• To use sterile containers/collection pots• Sterile reagents, slides and equipment• Do not use tap water for staining(saprophytic mycobacteria)• New slides only(old slides may harbour fungal spores in scratches)

Page 15: WHO recommended tests of tuberculosis

Reporting on AFB Microscopy

Number of bacilli seen Result reported

None per 100 oil immersion fields Negative

1-9 per 100 oil immersion fields Scanty, reportexact number

10-99 per 100 oil immersion fields 1+

1-10 per oil immersion field 2+

> 10 per oil immersion field 3+

Page 16: WHO recommended tests of tuberculosis

FLUORESCENT MICROSCOPY

Fluorescent dye (Auramine O and Rhodamine B)

• Good for labs with high workload. • Auramine O- Bright yellow • Rhodamine B- Yellow orange.

Page 17: WHO recommended tests of tuberculosis

Reporting in flouroscent techniqueNo of bacilli per HPF GRADE

<6 per field 1+

6-100 per field 2+

>100 per field 3+

Page 18: WHO recommended tests of tuberculosis

LED FLUORESCENCE MICROSCOPY (light emitting diode fluorescent microscopy)

Page 19: WHO recommended tests of tuberculosis
Page 20: WHO recommended tests of tuberculosis

LED FLUORESCENCE MICROSCOPY

• Increase the sensitivity of smear microscopy and improve the efficiency of facilities.

• Much larger area of the smear to be seen,

• More rapid examination of the specimen (up to four times faster) and making it easier to count bacilli.

• ADVANTAGES:

• More sustainable ,

• User-friendly than the quartz-halogen lamps or high-pressure mercury vapour lamps typically used in FM

Page 21: WHO recommended tests of tuberculosis

COMPARISON -overall sensitivity is 93% and specificity is 99% -6% more sensitive than Z-N microscopy & 5% more sensitive than conventional flouroscent microscopyRECOMMENDATIONS• conventional fluorescence microscopy be replaced by LED microscopy with auramine staining in all settings where fluorescence microscopy is currently used.• LED microscopy be phased in as an alternative to conventional Ziehl-Nelsen light microscopy.• the switch to LED microscopy be made according to a carefully phased implementation plan.

Page 22: WHO recommended tests of tuberculosis

SAME DAY DIAGNOSIS

• Same-day diagnosis ('spot-spot') versus the conventional strategy ('spot-morning'), with two specimens and direct Ziehl-Neelsen microscopy

-only 2.8% less sensitive and similar specificity•Same-day diagnosis ('spot-spot morning') versus the conventional strategy ('spot-morning-spot') with three specimens and direct Ziehl-Neelsen microscopy -3% more sensitive and similar specificity

Page 23: WHO recommended tests of tuberculosis

WHO RECOMMENDATIONS• countries that have implemented the current WHO policy for two-specimen case-finding consider switching to same-day diagnosis, especially in settings where patients are likely to default from the diagnostic pathway• countries that are still using the three-specimen case-finding strategy consider a gradual change to same-day diagnosis, once WHO-recommended external microscopy quality assurance systems are in place and good-quality microscopy results have been documented

Page 24: WHO recommended tests of tuberculosis

CULTURE METHODS

Page 25: WHO recommended tests of tuberculosis
Page 26: WHO recommended tests of tuberculosis

Less common media

• Powlowski potato media• Tarshish blood media• Dubos media• Sulas media• Soutons media

Page 27: WHO recommended tests of tuberculosis

Conditions for better growth

• Temp b’n 25-40c. Ideally 37c• 5-10% co2 enhances the growth• Ph 6.4-7• Addition of low percentage of glycerol to the medium enhances the

growth of human strains• Minimum time for growth to appear 2 weeks and can take upto 6-8

weeks

Page 28: WHO recommended tests of tuberculosis

Colony charecteristics

• M.TB: these are raised rough ,discrete, dry, wrinkled , creamy white• M.bovis: smooth , moist, white, break up more readily when touched

Page 29: WHO recommended tests of tuberculosis
Page 30: WHO recommended tests of tuberculosis

Rapid culture techniques

• BACTEC system• MB/BAC T system• Mycobact growth indicator tube (MGIT)• Septi chek AFB method• ESP culture system• Microscopic observation drug sensitivity(MODS)

Page 31: WHO recommended tests of tuberculosis

• BACTEC -Radiometric method -growth is ascertained by liberation of 14CO2 as metabolised by mycobacteria -average time: 8days -can also be used for drug susceptibility testing DRAWBACKS: -high cost -disposal of radiactive waste

Page 32: WHO recommended tests of tuberculosis
Page 33: WHO recommended tests of tuberculosis

MB/BacT SYSTEM

• Non radiometric continuous monitoring system• Based on calorimetric detection of co2• Slightly longer time than BACTEC (14 days)• Prone to contamination

Page 34: WHO recommended tests of tuberculosis
Page 35: WHO recommended tests of tuberculosis
Page 36: WHO recommended tests of tuberculosis

MGIT +ve tubes MGIT 960 instrument

Page 37: WHO recommended tests of tuberculosis

MGIT 320 System and Manual Reader

Holds 320 tubes for an annual capacity of approx 2700 specimens/year

Optimal use of valuable lab space

Flexible configuration as bench top or stand-mounted

Manual UV Reader as back up for MGIT 960/320

few specimens (in low load labs)

Power problems

MGIT tubes to be incubated in regular incubators

Page 38: WHO recommended tests of tuberculosis

Liquid Culture Systems MGIT 960

STRENGTH WEAKNESSAutomated system – growth & detection (except Blood)

Capacity to incubate & monitor 960 tubes

every 60 minutes for Increase in fluorescence

Can handle 8000 cultures/year

System alerts when tubes become +ve

No radioactive material used

Results available within 7-14 days

BSL III/negative Pressure Environment

Continuous Electricity

Reagent costs and AMC

High Contamination rates

Training in handling Liquid culture

Speciation if+ve*

Cold chain transport for sputUM

Page 39: WHO recommended tests of tuberculosis
Page 40: WHO recommended tests of tuberculosis

MODS – MICROSCOPIC OBSERVATION DRUG SUSCEPTIBILITY• Microscopic colonies (micro-colonies) of M. tuberculosis are

observed in the culture media using an inverted microscopeUses tissue culture plate - the wells coated with different drugs in different concentration are used

- presence of growth with INH /RIF /SM/EMB can be detected.

• Time taken 7 to 14 days

Page 41: WHO recommended tests of tuberculosis

MODS – MICROSCOPIC OBSERVATION DRUG SUSCEPTIBILITY

• difficulty distinguishing between the micro-colonies of TB and some nontuberculous mycobacteria (NTM).

• requires experienced personnel.• , biosafety of laboratory workers must be taken into consideration.

Page 42: WHO recommended tests of tuberculosis

STRIP SPECIATION• Detect a TB-specific antigen (MPB64) from positive liquid or solid

cultures to confirm the presence of organisms belonging to M.tuberculosis complex.

• Speciation is necessary to differentiate M.tuberculosis complex and other mycobacteria grown in cultures.

• ADVANTAGES:

• Results in 15 min

• Sensitivity & specificity of 98.6% and 97.9% • no additional equipment or consumables are needed to perform the test and can

detect TB even when mixed with nontuberculous mycobacteria.,

Page 43: WHO recommended tests of tuberculosis

STRIP SPECIATION

Page 44: WHO recommended tests of tuberculosis

Rapid Speciation of Positive Cultures • Immunochromatographic tests - Rapid strip test that

detects a TB-specific antigen (MPB 64) from culture• Bacterial growth derived from solid or liquid culture can be used

• Outputs:• Control band• Test band:

• Present = M.tb complex• Absent = not M.tb complex

• Increased yield of NTMs with liquid cultures necessitates prompt identification of mycobacterial growth as TB vs NTM

Page 45: WHO recommended tests of tuberculosis

COLORIMETRIC REDOX INDICATORS

• Based on the reduction of an indicator solution added to a liquid culture medium after TB organisms have been exposed to different antibiotics.

• Isoniazid and rifampicin resistance is detected by a change in colour of the indicator.

• ADVANTAGES:

• Highly sensitive (about 95%) and specific for the detection of MDR-TB

• Faster than conventional solid or liquid culture DST methods

• Results between 7 and 14 days after culturing.

• do not require sophisticated equipment

Page 46: WHO recommended tests of tuberculosis

LIQUID CULTURE SYSTEM

• liquid culture medium, enriched with oxygen

• As bacteria grows in the culture, the oxygen is utilized, causing it to be fluorescent when placed under UV light.

• ADVANTAGES:

• Faster

• High sensitivity &specificity nearly 100%

• Diagnosis in 7-14 days

• Both automated and manual systems perform well in detection of isoniazid and rifampicin susceptibility.

• Not as effective for ethambutol and streptomycin

Page 47: WHO recommended tests of tuberculosis

• Measures nitrate reduction to indicate resistance to isoniazid and rifampicin.• Based on the property of TB to reduce nitrate to nitrite& color change of the

culture media.

ADVANTAGES

NRA (NITRATE REDUCTION ASSAY)less expensive to than liquid culture techniques for DST• Results are earlier than by eye examination of colonies in solid culture• the specificity and sensitivity of NRA were comparable to traditional solid culture methods for DST

of isoniazid and rifampicin• . NRA does not need sophisticated equipment, is not complex to perform • Disadvantages• The culture is killed by the mix reagent used to develop the assay, requiring that multiple cultures

be prepared if comparative testing will be performed. Only fresh cultures must be used (<14 days).

NITRATE REDUCTION ASSAY

Page 48: WHO recommended tests of tuberculosis

Detection of mycobacteria directly from clinical samples• Genotypic methods {NAA}• PCR (polymerase chain reaction)• LAMP (loop mediated isothermal amplification)• TMA (transcription mediated amplification)• Ligase chain reaction• AMPLICOR assay• MTD test (mycobacterium tuberculosis direct test)• BD probe Tec MTB test• Phenotypic methods• FAST plaque TB method

Page 49: WHO recommended tests of tuberculosis
Page 50: WHO recommended tests of tuberculosis
Page 51: WHO recommended tests of tuberculosis
Page 52: WHO recommended tests of tuberculosis

LIMITATIONS OF NAA

• No drug susceptibility information• Detects nucleic acid from both dead and living organisms• May be falsely positive in persons having recent infection and

undergone treatment.

Page 53: WHO recommended tests of tuberculosis

• Line-probe assays are designed to identify M. tuberculosis complex and simultaneously detect mutations associated with drug resistance

• They are a family of novel DNA strip-based tests that use PCR and reverse hybridization methods for the rapid detection of mutations associated with drug resistance

• Line-probe assay has high sensitivity and specificity when culture isolates are used.

• The majority of studies had sensitivity of 95% or greater, and nearly all were 100% specific

Line Probe Assays

Page 54: WHO recommended tests of tuberculosis

Two commercial assays availableGenotype MTBDRplus (Hain LPA), INNO-LipA Rif.TB

Validated for use directly from smear-positive sputum (MTBDRplus) or from TB cultures

Manual and automated systems Twincubator – 10 /runGT Blot – 48/run

rpoB for rifampicin resistance (InnoLiPA)rpoB for rifampicin, katG and inhA for isoniazid resistance (MTBDRplus)

Commercial Assays

Page 55: WHO recommended tests of tuberculosis

Results of Hain MTBDRplus•97% of smear-positive specimens gave results within 1–2 days (24-48 hrs)•Good sensitivity and specificity -Rifampin: sensitivity: 98%; specificity: 99% -Isoniazid: sensitivity: 89%, specificity: 99%

Page 56: WHO recommended tests of tuberculosis

Same technology as Hains MDRplusTarget genes identified are:• FQ – gyrA (oflox, Moxi)• Aminoglycosides and Polypeptides –rrs (Kana, Amik, Vio,

Capreo)• EMB- embB (Ethambutol)

LPA for diagnosis of XDR TB

Page 57: WHO recommended tests of tuberculosis

Use of LPA under the programIntegrated national plan for LPAswith MDR-TB management and lab capacity strengthening

Use of LPAs on smear-positivesputum and from cultures if smear negative (insufficient evidence for direct testing in smear negatives)

LPAs do not replace conventional culture + DST

Commercial assays recommendedLab infrastructure, procedures andbiosafety

Page 58: WHO recommended tests of tuberculosis

GENEXPERT® MTB/RIF

1. The new, rapid and fully automated Xpert®

2. MTB/RIF test is cartridge-based automated DNA amplification test

3. Highly sensitive for confirmation of both smear positive and smear negative samples.

4. The Xpert® MTB/RIF assay uses 3 specific primers and 5 unique molecular probes to ensure a high degree of specificity

5. Assay targets the rpoB gene, which is critical for identifying mutations associated with rifampicin resistance

Page 59: WHO recommended tests of tuberculosis

GENEXPERT® MTB/RIF

1. Advantages:• highly accurate results in less than 2 hours.

• Simultaneous detection of both MTB and rifampicin resistance,

• up to 95% of rifampicin resistance strains are INH resistance

Page 60: WHO recommended tests of tuberculosis

Xpert MTB/RIF assay & GeneXpert instrument

• diagnostic molecular test that uses modern technology:

• Extraction andpurificationDNA/RNA

&

• Amplification

&

• Multiplex detection

(automated)

Page 61: WHO recommended tests of tuberculosis

Xpert MTB/RIF assay & GeneXpert instrument

Page 62: WHO recommended tests of tuberculosis

Xpert MTB/RIF assay & GeneXpert instrument

• Closed system – no contamination risk

• Controls – Positive control included in test kit

• Reagents – All reagents in self-contains kit, kit contains a pipette to transfer liquid sputum from container to cartridge

• Storage/stability (including reagents) – Maximum shelf-life of 14 months

Page 63: WHO recommended tests of tuberculosis

Xpert MTB/RIF assay & GeneXpert instrument• Reagents stable at temperature 2-280

• Instrumentations – Requires annual maintenance

• Power requirement – Low power requirement compared with other PCR system

• Training – Approximately 1 day of training required

Page 64: WHO recommended tests of tuberculosis

Sensitivity for AFB+/culture+ 98.2%

• Sensitivity for AFB-/culture+ 72.5%

• Specificity 99.2%

Rifampicin resistance detection

Sensitivity – 98%

• Specificity – 99%

Xpert MTB/RIF assay & GeneXpert instrument

Sensitivity and specificity

Page 65: WHO recommended tests of tuberculosis

WHO RECOMMENDATIONS ON XPERT MTB/RIF

• SHOULD BE USED: -as the initial diagnostic test in adults and children presumed to have MDR-TB or HIV-associated TB -as the initial diagnostic test in testing cerebrospinal fluid specimens from patients presumed to have TB meningitis

Page 66: WHO recommended tests of tuberculosis

• MAY BE USED: -as the initial diagnostic test in adults and children presumed to have TB -as a follow-on test to microscopy in adults presumed to have TB but not at risk of MDR-TB or HIV-associated TB, especially in further testing of smear-negative specimens -as a replacement test for usual practice (including conventional microscopy, culture, and/or histopathology) -for testing of specific non-respiratory specimens (lymph nodes and other tissues) from patients presumed to have extrapulmonary TB

Page 67: WHO recommended tests of tuberculosis

Drug Susceptibility Testing

7 - 10 days

3 - 4 weeksSolid MediaLöwenstein-Jensen(Middlebrook)

Liquid MediaBACTEC 460 TBMGIT

Molecular based MethodsInnoLipaGenoTypeMTBDRXpert MTB‚home made‘- methods

Hours – 1day

Page 68: WHO recommended tests of tuberculosis
Page 69: WHO recommended tests of tuberculosis

Indirect tests

• ANTIBODY DETECTION• TB stat PAK• ELISA• INSTA TB TEST• ANTIGEN DETECTION• TB MPB 64 PATCH TEST

Page 70: WHO recommended tests of tuberculosis

INTERFERON GAMMA RELEASE ASSAY

• much less likely than the tuberculin skin tests (TST) to be confounded by exposure to environmental mycobacteria or by prior BCG vaccination. Does not boost responses

• do not require a second clinical contact to evaluate the test result,• better sensitivity for HIV-infected people and patients with extrapulmonary TB• Disadvantages • lower sensitivity than the TST for past infection. Assays do not discriminate between active and

latent TB infection.• moderately complex and requires standard ELISA equipment • . Blood samples have to be incubated within 16 hours of being collected, which may require the

use of portable incubators• Requires that blood be drawn from the patient with a needle, which can lead to other infections.• application of such tests in disease-endemic, developing countries is the subject of extensive

investigation.

Page 71: WHO recommended tests of tuberculosis

INTERFERON GAMMA RELEASE ASSAY

Page 72: WHO recommended tests of tuberculosis
Page 73: WHO recommended tests of tuberculosis
Page 74: WHO recommended tests of tuberculosis
Page 75: WHO recommended tests of tuberculosis
Page 76: WHO recommended tests of tuberculosis
Page 77: WHO recommended tests of tuberculosis

There is insufficient data and low quality evidence on the performance of IGRAs in low- and middle-income countries, typically those with a high TB and/or HIV burden • IGRAs and the tuberculin skin test (TST) cannot accurately predict the risk of infected individuals developing active TB disease • Neither IGRAs nor the TST should be used for the diagnosis of active TB disease

Page 78: WHO recommended tests of tuberculosis
Page 79: WHO recommended tests of tuberculosis

WHO RECOMMENDATIONS

RECOMMENDED NOT TO USE :• Commercial TB serodiagnostic tests. • Interferon-gamma release assays for detection of active TB (all settings).

Page 80: WHO recommended tests of tuberculosis

Sensitivity (cfu/ml) of pulmonary TB diagnostics

Solidculture

Page 81: WHO recommended tests of tuberculosis

Phage based tests

Page 82: WHO recommended tests of tuberculosis
Page 83: WHO recommended tests of tuberculosis
Page 84: WHO recommended tests of tuberculosis
Page 85: WHO recommended tests of tuberculosis
Page 86: WHO recommended tests of tuberculosis

• Can also be used on urine samples• Results available in 1 day• As it is cheap can be used in resource poor countries

Page 87: WHO recommended tests of tuberculosis
Page 88: WHO recommended tests of tuberculosis

TESTS BEING REVIEWED BY WHO IN 2015• TB LAMP (loop mediated isothermal amplication)• URINARY LAM (lipoarabinomannan)• MOLECULAR DST METHODS- hains MTBDR sl tests

Page 89: WHO recommended tests of tuberculosis

TECHNOLOGIES IN DEVELOPMENT• VOLATILE ORGANIC COMPOUNDS -breathlink -prototype breath analyser deviceMOLECULAR TECHNOLOGIES -alere Q -B SMART -genedrive MTB/RIF ID -LATE PCR -genepert XDR catridge -trueArray MDRTB -INFITINIMTB assay -fluorotype MTB/ fluorotype MTB RNA

Page 90: WHO recommended tests of tuberculosis

• CULTURE BASED TECHNOLOGIES -BNP middlebrook -TREK sensititre MYCOTB mic plateOTHER TECHOLOGIES -TB rapid screen -TBDx

Page 91: WHO recommended tests of tuberculosis

OVERVIEW OF WHO RECOMMENDATIONS

Page 92: WHO recommended tests of tuberculosis

• LED microscopy: For use at all laboratory levels as replacement of conventional fluorochrome and light microscopy.

• Commercial liquid culture and DST systems: For use at central/regional reference laboratory level, as current reference standard. • Rapid speciation strip technology: For use with conventional culture and DST at central/regional reference laboratory level, to identify Mycobacterium tuberculosis. • Commercial molecular line probe assays for 1st-line anti-TB drugs: For use at central/regional reference laboratory level for rapid detection of rifampicin (alone or with isoniazid) resistance. Suitable for use on smearpositive specimens or culture isolates.

Page 93: WHO recommended tests of tuberculosis

• Selected non-commercial DST methods: MODS(microscopic observation of drug susceptibility), NRA(nitrate reductase assay), CRI(calorimetric redox indicator): For conditional use at central/reference laboratory level for detection of rifampicin resistance only. MODS and NRA suitable for use on smear-positive specimens or culture isolates, CRI suitable for use on culture isolates only. • Automated real-time nucleic acid amplification - Xpert MTB/RIF system: For rapid detection of pulmonary and extrapulmonary TB and rifampicin resistance in both adults and children at decentralised laboratory and health care centres.

Page 94: WHO recommended tests of tuberculosis

NOT RECOMMENDED DUE TO CURRENT INSUFFICIENT EVIDENCE • Sputum concentration and decontamination methods. • Phage-plaque technology for rapid rifampicin resistance. • Thin-layer agar methods for rapid culture and DST. • Interferon-gamma release assays as replacement for the tuberculin skin test for detection of latent TB in low- and middle-income (typically high TB and/or HIV) settings. • Molecular line probe assays for 2nd-line anti-TB drugs. • Loop-mediated isothermal amplification test kit for TB.

Page 95: WHO recommended tests of tuberculosis

RECOMMENDED NOT TO USE :• Commercial TB serodiagnostic tests. • Interferon-gamma release assays for detection of active TB (all settings).

Page 96: WHO recommended tests of tuberculosis

THANK YOU